Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Anti-tumor pharmacological evaluation of extracts from stellera chamaejasme L based on hollow fiber assay

Authors: Xiaoni Liu, Qing Yang, Ganlin Zhang, Yujie Li, Ying Chen, Xiaogang Weng, Yajie Wang, Yiwei Wang, Xiaoxin Zhu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

Stellera chamaejasme L, a traditional Chinese herb, has long been used for treatment of various tumors in the Chinese population. In our previous study, we paid an attention to the cytotoxic and proapoptotic effects of Stellera chamaejasme L extracts (ESC, ESC-1 and ESC-2, the latter two were isolated from ESC) on 4 various tumor cells (NCI-H157, NCI-H460, BEL-7402 and SK-HEP-1) in vitro. ESCs showed significantly inhibitory effects on the 4 tumor cells. ESC-2 had the strongest inhibitory effect and the broadest sensitive cell spectrum. ESC-2 and ESC acted in a similar way against tumor cells, which suggested anti-tumor active fraction of ESC might exist in ESC-2. Here, we further observe the inhibitory and proapoptotic effects of Stellera chamaejasme L extracts in vivo.

Methods

In this study, we used hollow fiber tumor model to evaluate the inhibitory and proapoptotic effects of Stellera chamaejasme L extracts. Apoptotic rates of the cancer cells retrieved from the hollow fibers were measured with flow cytometric analysis, caspase 3, 8, 9 enzyme activities were detected by colorimetric assay, Fas, Fas-L, TNF-R1 and TNF-α expression were determined with elisa assay and radioimmunoassay respectively.

Results

The results showed that ESC, ESC-2 all had inhibitory effects on 4 tumor cells. According to the effect strength, dose and antitumor spectrum, the order of antitumor effects of ESCs was: ESC-2 > ESC > ESC-1. NCI-H460 cells were the most sensitive to ESCs. ESC, ESC-2 increased greatly the apoptotic rate and caspase 3, 8 enzyme activities in NCI-H460. ESCs had no significant effects on expression of Fas, Fas-L protein, but TNF-α/TNFR1 protein expression in NCI-H460 cells changed significantly after ESC and ESC-2 treatment.

Conclusion

ESC-2 had the similar antitumor effect to that of ESC in vivo and further confirmed that ESC-2 may be the main antitumor active fraction of ESC, which was consistent with our previous results in vitro.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR: In vivo cultivation of tumor cells in hollow fibers. Life Sci. 1995, 52: 131-141.CrossRef Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, Grever MR: In vivo cultivation of tumor cells in hollow fibers. Life Sci. 1995, 52: 131-141.CrossRef
2.
go back to reference Melinda G, Hollingshead MG, Carter JP, Dougherty K, Bonomi CA: The Hollow Fiber Assay In Cancer Efficacy Testing In The Developmental Therapeutics Program At The National Cancer Institute. 2005, : AACR Education Book, 351-354. Melinda G, Hollingshead MG, Carter JP, Dougherty K, Bonomi CA: The Hollow Fiber Assay In Cancer Efficacy Testing In The Developmental Therapeutics Program At The National Cancer Institute. 2005, : AACR Education Book, 351-354.
3.
go back to reference Liu X, Yang Q, Li Y, Pan G, Han X, Weng X, Zhang Y, Wang Y, Zhu X: Application of hollow fiber assay in anti-Cancer drug research. Acta Laboratorium Animalis Scientia. 2009, 17: 392-396. Liu X, Yang Q, Li Y, Pan G, Han X, Weng X, Zhang Y, Wang Y, Zhu X: Application of hollow fiber assay in anti-Cancer drug research. Acta Laboratorium Animalis Scientia. 2009, 17: 392-396.
4.
go back to reference Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM: Pervilleines B and C, new tropane alkaloid aromatic esters that reverse the multidrug-resistance in the hollow fiber assay. Cancer Lett. 2002, 184: 13-20. 10.1016/S0304-3835(02)00202-1.CrossRefPubMed Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM: Pervilleines B and C, new tropane alkaloid aromatic esters that reverse the multidrug-resistance in the hollow fiber assay. Cancer Lett. 2002, 184: 13-20. 10.1016/S0304-3835(02)00202-1.CrossRefPubMed
5.
go back to reference Hassan S, Dhar S: Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo. Cancer Chemother Pharmacol. 2005, 55: 47-54. 10.1007/s00280-004-0855-5.CrossRefPubMed Hassan S, Dhar S: Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo. Cancer Chemother Pharmacol. 2005, 55: 47-54. 10.1007/s00280-004-0855-5.CrossRefPubMed
6.
go back to reference Suggitt M, Cooper PA, Shnyder SD, Bibby MC: The hollow fibre model facilitating anti-cancer preclinical pharmacodynamics and improving animal welfare. Int J Oncol. 2006, 291: 493-1499. Suggitt M, Cooper PA, Shnyder SD, Bibby MC: The hollow fibre model facilitating anti-cancer preclinical pharmacodynamics and improving animal welfare. Int J Oncol. 2006, 291: 493-1499.
7.
go back to reference Kiakos K, Sato A, Asao T, McHugh PJ, Lee M, Hartley JA: DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz [e] indolone analogue of duocarmycin AS-I-145. Mol Cancer Ther. 2007, 6: 2708-2718. 10.1158/1535-7163.MCT-07-0294.CrossRefPubMed Kiakos K, Sato A, Asao T, McHugh PJ, Lee M, Hartley JA: DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz [e] indolone analogue of duocarmycin AS-I-145. Mol Cancer Ther. 2007, 6: 2708-2718. 10.1158/1535-7163.MCT-07-0294.CrossRefPubMed
8.
go back to reference Li XL, Liu JY, Lu R, Xu Q, Zhu ZF, Wang L, Zhou CL, Jia J, Fu Z, Yao Z: Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay. Invest New Drugs. 2008, 26: 525-529. 10.1007/s10637-008-9121-8.CrossRefPubMed Li XL, Liu JY, Lu R, Xu Q, Zhu ZF, Wang L, Zhou CL, Jia J, Fu Z, Yao Z: Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay. Invest New Drugs. 2008, 26: 525-529. 10.1007/s10637-008-9121-8.CrossRefPubMed
9.
go back to reference Temmink OH, Prins HJ, van Gelderop E, Peters GJ: The hollow fibre assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells. Br J Cancer. 2007, 2007: 96- Temmink OH, Prins HJ, van Gelderop E, Peters GJ: The hollow fibre assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells. Br J Cancer. 2007, 2007: 96-
10.
go back to reference Hall LA, Krauthauser CM, Wexler RS, Hollingshead MG, Slee AM, Kerr JS: The hollow fiber assay:continued characterization with novel approaches. Anticancer Res. 2000, 20: 903-911.PubMed Hall LA, Krauthauser CM, Wexler RS, Hollingshead MG, Slee AM, Kerr JS: The hollow fiber assay:continued characterization with novel approaches. Anticancer Res. 2000, 20: 903-911.PubMed
11.
go back to reference Krauthauser CM, Hall LA, Wexler RS, Slee AM, Mitra J, Enders GH, Kerr JS: Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assay. Anticancer Res. 2001, 21: 869-872.PubMed Krauthauser CM, Hall LA, Wexler RS, Slee AM, Mitra J, Enders GH, Kerr JS: Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assay. Anticancer Res. 2001, 21: 869-872.PubMed
12.
go back to reference Zhang GJ, Chen TB, Hargreaves R, Sur C, Williams DL: Bioluminescence imaging of hollow fibers in living animals: its application in monitoring molecular pathways. Nat Protoc. 2008, 3: 891-899. 10.1038/nprot.2008.52.CrossRefPubMed Zhang GJ, Chen TB, Hargreaves R, Sur C, Williams DL: Bioluminescence imaging of hollow fibers in living animals: its application in monitoring molecular pathways. Nat Protoc. 2008, 3: 891-899. 10.1038/nprot.2008.52.CrossRefPubMed
13.
go back to reference Liu X, Li Y, Yang Q, Liu A, Zhu X: Anti-tumor effect of alcohol extract of Stellera chamaejasme in vitro. Zhongguo Zhong Yao Za Zhi. 2010, 35: 3048-3051.PubMed Liu X, Li Y, Yang Q, Liu A, Zhu X: Anti-tumor effect of alcohol extract of Stellera chamaejasme in vitro. Zhongguo Zhong Yao Za Zhi. 2010, 35: 3048-3051.PubMed
14.
go back to reference Liu X, Li Y, Yang Q, Chen Y, Weng X, Wang Y, Li N, Zhu X: In vitro inhibitory and pro-apoptotic effect of stellera chamaejasme L extract on human lung cancer cell line NCI-H157. J Tradit Chin Med. 2012, 32: 404-410. 10.1016/S0254-6272(13)60046-1.CrossRefPubMed Liu X, Li Y, Yang Q, Chen Y, Weng X, Wang Y, Li N, Zhu X: In vitro inhibitory and pro-apoptotic effect of stellera chamaejasme L extract on human lung cancer cell line NCI-H157. J Tradit Chin Med. 2012, 32: 404-410. 10.1016/S0254-6272(13)60046-1.CrossRefPubMed
15.
go back to reference Liu X, Zhu X: Stellera chamaejasme L. extract induces apoptosis of human lung cancer cells via activation of the death receptor-dependent pathway. Exp Ther Med. 2012, 4: 605-610.PubMedPubMedCentral Liu X, Zhu X: Stellera chamaejasme L. extract induces apoptosis of human lung cancer cells via activation of the death receptor-dependent pathway. Exp Ther Med. 2012, 4: 605-610.PubMedPubMedCentral
16.
go back to reference Situ Z, Wu J: Cells Culture. 1996, : Xi’an world publishing corporation, 135- Situ Z, Wu J: Cells Culture. 1996, : Xi’an world publishing corporation, 135-
17.
go back to reference Thorburn A: Death receptor-induced cell killing. Cell Signal. 2004, 16: 139-144. 10.1016/j.cellsig.2003.08.007.CrossRefPubMed Thorburn A: Death receptor-induced cell killing. Cell Signal. 2004, 16: 139-144. 10.1016/j.cellsig.2003.08.007.CrossRefPubMed
18.
go back to reference Rübe CE, van Valen F, Wilfert F, Palm J, Schuck A, Willich N, Winkelmann W, Jürgens H, Rübe C: Ewing’s sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys. 2003, 56: 1414-1425. 10.1016/S0360-3016(03)00418-8.CrossRefPubMed Rübe CE, van Valen F, Wilfert F, Palm J, Schuck A, Willich N, Winkelmann W, Jürgens H, Rübe C: Ewing’s sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys. 2003, 56: 1414-1425. 10.1016/S0360-3016(03)00418-8.CrossRefPubMed
19.
go back to reference Fedorocko P, Egyed A, Vacek A: Irradiation induces increasedproduction of haemopoietic and proinflammatory cytokines in the mouse lung. Int J Radiat Biol. 2002, 78: 305-313. 10.1080/09553000110104614.CrossRefPubMed Fedorocko P, Egyed A, Vacek A: Irradiation induces increasedproduction of haemopoietic and proinflammatory cytokines in the mouse lung. Int J Radiat Biol. 2002, 78: 305-313. 10.1080/09553000110104614.CrossRefPubMed
20.
go back to reference Gupta VK, Park JO, Jaskowiak NT, Mauceri HJ, Seetharam S, Weichselbaum RR, Posner MC: Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol. 2002, 9: 500-504. 10.1007/BF02557275.CrossRefPubMed Gupta VK, Park JO, Jaskowiak NT, Mauceri HJ, Seetharam S, Weichselbaum RR, Posner MC: Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol. 2002, 9: 500-504. 10.1007/BF02557275.CrossRefPubMed
21.
go back to reference Rübe CE, Wifert F, Uthe D, Schmid KW, Knoop R, Willich N, Schuck A, Rübe C: Modulation of irradiation-induced tumor necrosis factor (TNF-α) expression in the lung tissue by pentoxifyline. Radiother Oncol. 2002, 64: 177-187. 10.1016/S0167-8140(02)00077-4.CrossRefPubMed Rübe CE, Wifert F, Uthe D, Schmid KW, Knoop R, Willich N, Schuck A, Rübe C: Modulation of irradiation-induced tumor necrosis factor (TNF-α) expression in the lung tissue by pentoxifyline. Radiother Oncol. 2002, 64: 177-187. 10.1016/S0167-8140(02)00077-4.CrossRefPubMed
22.
go back to reference Himeno T, Watanabe N, Yamauchi N, Maeda M, Tsuji Y, Okamoto T, Neda H, Niitsu Y: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res. 1990, 50: 4941-4945.PubMed Himeno T, Watanabe N, Yamauchi N, Maeda M, Tsuji Y, Okamoto T, Neda H, Niitsu Y: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res. 1990, 50: 4941-4945.PubMed
23.
go back to reference Rübe CE, van Valen F, Wifert F, Schuck A, Willich N, Winkelmann W, Jürgens H, Rübe C: Ewing’s sarcoma and peripheral primitive neuro-ecto-dermal tumor cells produce large quantities of bioactive tumor necrosis factor-α (TNF-α) after radiation exposure. Int J Radiation Oncology Biol Phys. 2003, 56: 1414-1425. 10.1016/S0360-3016(03)00418-8.CrossRef Rübe CE, van Valen F, Wifert F, Schuck A, Willich N, Winkelmann W, Jürgens H, Rübe C: Ewing’s sarcoma and peripheral primitive neuro-ecto-dermal tumor cells produce large quantities of bioactive tumor necrosis factor-α (TNF-α) after radiation exposure. Int J Radiation Oncology Biol Phys. 2003, 56: 1414-1425. 10.1016/S0360-3016(03)00418-8.CrossRef
24.
go back to reference Chosa N, Kyakumoto S, Kito N, Kamo M, Sato N: Mechanism of Fas-mediated cell death and its enhancement by TNF-alpha in human salivary gland adenocarcinoma cell line HSG. Eur J Oral Sci. 2004, 112: 338-346. 10.1111/j.1600-0722.2004.00145.x.CrossRefPubMed Chosa N, Kyakumoto S, Kito N, Kamo M, Sato N: Mechanism of Fas-mediated cell death and its enhancement by TNF-alpha in human salivary gland adenocarcinoma cell line HSG. Eur J Oral Sci. 2004, 112: 338-346. 10.1111/j.1600-0722.2004.00145.x.CrossRefPubMed
25.
go back to reference Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M: The E3 ubiquitin ligase itch couples JNK activation to TNF alpha-induced cell death by inducing c-FLIP(L) turn over. Cell. 2006, 124: 601-613. 10.1016/j.cell.2006.01.021.CrossRefPubMed Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M: The E3 ubiquitin ligase itch couples JNK activation to TNF alpha-induced cell death by inducing c-FLIP(L) turn over. Cell. 2006, 124: 601-613. 10.1016/j.cell.2006.01.021.CrossRefPubMed
26.
go back to reference Wang WH, Grégori G, Hullinger RL, Andrisani OM: Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Mol Cell Biol. 2004, 24: 10352-10365. 10.1128/MCB.24.23.10352-10365.2004.CrossRefPubMedPubMedCentral Wang WH, Grégori G, Hullinger RL, Andrisani OM: Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Mol Cell Biol. 2004, 24: 10352-10365. 10.1128/MCB.24.23.10352-10365.2004.CrossRefPubMedPubMedCentral
Metadata
Title
Anti-tumor pharmacological evaluation of extracts from stellera chamaejasme L based on hollow fiber assay
Authors
Xiaoni Liu
Qing Yang
Ganlin Zhang
Yujie Li
Ying Chen
Xiaogang Weng
Yajie Wang
Yiwei Wang
Xiaoxin Zhu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-116

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue